NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹626 Cr | ₹638 Cr | ₹486 Cr | ₹606 Cr | ₹604 Cr |
What is the latest Short Term Loans and Advances ratio of NATCO PHARMA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹626 Cr |
| Mar2024 | ₹638 Cr |
| Mar2023 | ₹486 Cr |
| Mar2022 | ₹606 Cr |
| Mar2021 | ₹604 Cr |
How is Short Term Loans and Advances of NATCO PHARMA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹626 Cr | -1.96 | |
| Mar2024 | ₹638 Cr | 31.43 | |
| Mar2023 | ₹486 Cr | -19.89 | |
| Mar2022 | ₹606 Cr | 0.41 | |
| Mar2021 | ₹604 Cr | - | |
Compare Short Term Loans and Advances of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹20,271.4 Cr | -3.5% | 1.2% | 41.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -3.5% |
1.2% |
41.1% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses